Take the Quiz
Brand GLP-1 telehealth provider

Hims & Hers

Semaglutide
Hims & Hers compounded semaglutide injection vial — editorial illustration
Provider Review · 74/100 · Updated October 16, 2026

Hims & Hers Review

Mass-market telehealth scale. Brand medication only — no compounded semaglutide or tirzepatide on its pages (September–October 2026); about $298–$448 a month all-in with the membership. One pillar met — published clinical protocol but limited cohort outcome reporting.

#7 of 974/100semaglutide oral $298/mo all-in (brand); tirzepatide vial $448/mo all-in (brand)
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Compare with our top-rated provider: NexLife — 94/100 (May 2026 review). Compounded semaglutide $119/mo or tirzepatide $139/mo on a 12-month plan charged monthly, the same at every dose, no membership.Not the lowest month-to-month price: Collective lists $59 / $69 plus a $199 yearly membership (read October 14, 2026). Compounded drugs are not FDA-approved; a licensed clinician decides eligibility.
See NexLife plansCompare all
Price check, September 20, 2026 — read on Hims & Hers’ own pages, computed from the open dataset:
Semaglutide · brand oral: $298/mo all-in — $149 medication + $149/month membership (brand product; medication rises by dose) membership stacked rises with dose. Weight-loss page read 2026-09-17: no compounded semaglutide or tirzepatide is offered; brand medication 'From $149/mo†' (Wegovy pill, Ozempic pill, Foundayo pill), 'From $199/mo†' (Wegovy pen, Ozempic), 'From $299/mo†' (Zepbound vial and Zepbound KwikPen), Mounjaro and Zepbound pens '$1,899/mo†'; First-party hims.com · 2026-09-17
Tirzepatide · brand vial: $448/mo all-in — $299 medication + $149/month membership (brand product; medication rises by dose) membership stacked rises with dose. Weight-loss page read 2026-09-17: no compounded semaglutide or tirzepatide is offered; brand medication 'From $149/mo†' (Wegovy pill, Ozempic pill, Foundayo pill), 'From $199/mo†' (Wegovy pen, Ozempic), 'From $299/mo†' (Zepbound vial and Zepbound KwikPen), Mounjaro and Zepbound pens '$1,899/mo†'; First-party hims.com · 2026-09-17
For comparison — NexLife’s 12-month rates charged monthly: tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “last updated” date; this block is regenerated on every update.

Overview

Mass-market telehealth scale. Brand medication only — no compounded semaglutide or tirzepatide on its pages (September–October 2026); about $298–$448 a month all-in with the membership. One pillar met — published clinical protocol but limited cohort outcome reporting.

Hims & Hers at a glance

Editorial rank
#7 of 9
Score
74/100 · 3.8/5 stars
Pillars met
1 of 6
Pricing
semaglutide oral $298/mo all-in (brand); tirzepatide vial $448/mo all-in (brand)
Pharmacy model
Compounded + brand
Clinical model
Mass-market telehealth

Six-pillar scoring

Hims & Hers meets 1 of 6 v3.0 transparency pillars. Single pillar met typically reflects a published clinical protocol but limited disclosure on pharmacy traceability, cohort outcomes, or pricing structure.

Pricing

semaglutide oral $298/mo all-in (brand); tirzepatide vial $448/mo all-in (brand). Verify final pricing directly with the provider before purchasing — prices may change.

Trade-offs to know

How to evaluate Hims & Hers

If you're considering Hims & Hers, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.

Visit Hims & Hers →

Questions readers ask

Does Hims & Hers still sell compounded GLP-1s?

Its weight-loss page, read September 17, 2026, offered no compounded semaglutide or tirzepatide. It lists brand medication instead, including the Wegovy pill, Foundayo, the Wegovy pen and Zepbound.

What does Hims & Hers cost all-in?

Read September 17, 2026: brand oral semaglutide is about $298 a month ($149 medication plus a $149 membership) and a Zepbound vial about $448 ($299 plus $149). Medication prices rise with dose.

How much of the Hims & Hers price is the membership?

About $149 a month. Manufacturers list the Wegovy pill from $149 a month via NovoCare and Zepbound at $299 for 2.5 mg via LillyDirect (read October 14, 2026), so the membership adds $149 a month on top of the manufacturer’s starting price.

What score does Hims & Hers have?

Hims & Hers scores 74/100 on the v3.0 rubric, ranked seventh of ten, meeting 1 of 6 transparency pillars: a published clinical protocol but limited cohort outcome reporting.

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Compounding and the FDA — questions and answers
  4. FDA: Registered outsourcing facilities (503B)
  5. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
  6. Wegovy (semaglutide) prescribing information, Novo Nordisk